How Met-Enkephalin in the Spinal Cord Helps Block Pain Signals | Research

The takeaway

Spinal cord met-enkephalin release is a key part of how brain-administered opioids reduce pain perception in mice.

Spinal met-enkephalin release
Significantly increased following brain opioid stimulation, contributing to pain relief via delta-opioid receptors

What the researchers found

Intracerebroventricular etorphine increases met-enkephalin release in the spinal cord, and this spinal opioid mechanism accounts for a significant portion of the observed pain relief.

Why it matters

Understanding how the brain's pain control system uses enkephalin peptides in the spinal cord could lead to more targeted pain therapies that work with the body's natural opioid systems rather than relying solely on external drugs.

How the study worked

In vivo mouse study using intracerebroventricular drug administration, tail-flick antinociception testing, spinal microdialysis to measure peptide release, and opioid receptor antagonists to identify receptor subtypes.

What this study cannot tell us

Mouse model may not fully translate to human pain processing. Only one opioid agonist (etorphine) was tested. Spinal microdialysis provides regional but not cellular-level resolution of peptide release.

How to read the evidence

Animal study with rigorous methodology including microdialysis and receptor-selective antagonists, but findings require human translation.

When this study was published

Published in 1997, this study established foundational knowledge about descending opioid pain pathways that remains relevant to current pain research.

The bigger picture

This research maps out a critical circuit in the body's natural pain defense: the brain activates descending pathways that release enkephalins in the spinal cord. This brain-to-spine opioid relay is fundamental to understanding how endogenous peptides modulate pain and could inform development of therapies targeting specific nodes in this pathway.

Questions still open

Could targeting spinal enkephalin release specifically reduce the need for systemic opioid dosing?
Do chronic pain conditions alter this brain-to-spine enkephalin relay?
How do other endogenous opioid peptides (dynorphin, endorphin) interact with this spinal mechanism?

Common questions

What is met-enkephalin and what does it do?

Met-enkephalin is a naturally produced opioid peptide in the body that helps reduce pain. It works by binding to delta-opioid receptors, particularly in the spinal cord, as part of the body's built-in pain management system.

Why does this matter for pain treatment?

Understanding that the brain controls pain partly by triggering enkephalin release in the spinal cord could lead to treatments that enhance this natural mechanism, potentially offering pain relief with fewer side effects than traditional opioids.

Read the original research

[Met]enkephalin in the spinal cord is involved in the antinociception induced by intracerebroventricularly-administered etorphine in the mouse.

Neuroscience, 80(2), 579-85

View on PubMed ↗

Citation

Xu, J Y; Tseng, L F. (1997). [Met]enkephalin in the spinal cord is involved in the antinociception induced by intracerebroventricularly-administered etorphine in the mouse.. Neuroscience, 80(2), 579-85.